Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a cash flow conversion efficiency ratio of -0.064x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.37 Million) by net assets ($287.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Kestra Medical Technologies, Ltd. Common market capitalisation for the company's overall valuation and market capitalisation.
Kestra Medical Technologies, Ltd. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their cash flow conversion efficiency. See debt repayment capacity of Kestra Medical Technologies, Ltd. Common to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xiamen Solex High-Tech Industries Co Ltd
SHG:603992
|
0.021x |
|
Adriatic Metals Plc
F:3FN
|
-0.035x |
|
Xpel Inc
NASDAQ:XPEL
|
0.121x |
|
Capital Clean Energy Carriers Corp.
NASDAQ:CCEC
|
0.040x |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
|
N/A |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
|
0.020x |
|
H Lundbeck A/S
CO:HLUN-A
|
0.014x |
|
Kraken Robotics Inc
V:PNG
|
-0.049x |
Annual Cash Flow Conversion Efficiency for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. View Kestra Medical Technologies, Ltd. Common (KMTS) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.41 Million | $-77.61 Million | -0.378x | -209.52% |
| 2024-04-30 | $-209.38 Million | $-72.23 Million | 0.345x | -41.75% |
| 2023-04-30 | $-117.58 Million | $-69.64 Million | 0.592x | +103.50% |
| 2021-04-30 | $1.77 Million | $-29.89 Million | -16.928x | -115.53% |
| 2020-04-30 | $3.86 Million | $-30.29 Million | -7.854x | -- |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more